Oasmia Pharmaceutical AB Employee Benefits Expense
Oasmia Pharmaceutical AB reported Employee Benefits Expense of SEK 48.37 million for the 12-month period ending 2018-04-30, per its 20-F filed 2018-09-14.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:EmployeeBenefitsExpense · last filed 2018-09-14
| Period end | Employee Benefits Expense 12 month |
|---|---|
| 2018-04-30 | 48.37M SEK 20-F · filed 2018-09-14 |
| 2017-04-30 | 59.30M SEK 20-F · filed 2018-09-14 |
| 2016-04-30 | 57.66M SEK 20-F · filed 2018-09-14 |